[Personalized medicine with extended-release trazodone and/or once-a-day trazodone: from research trials to clinical practice].
DISCUSSION: The different formulations of trazodone allow a personalization of the treatment, which may be targeted to the specific needs of each patient.
PMID: 33078017 [PubMed - in process]
Source: Rivista di Psichiatria - Category: Psychiatry Tags: Riv Psichiatr Source Type: research
More News: Anxiety | Databases & Libraries | Depression | Insomnia | Italy Health | Psychiatry | Sleep Disorders | Sleep Medicine | Trazodone | USA Health